Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records

Cardiovasc Diabetol. 2023 Nov 28;22(1):329. doi: 10.1186/s12933-023-02069-y.

Kamel Mohammedi^{1

2}, Audrey Cordon³, Vincent Rigalleau^{4

5}, Ninon Foussard^{4

6}, Céline Bairras-Martin⁷, Thierry Couffinhal^{4

8}, Julien Bezin^{9

10}, Antoine Benard^{3

11}

¹ Univ. Bordeaux, INSERM, BMC, U1034, 33600, Pessac, France. [email protected].
² Department of Endocrinology, Diabetes and Nutrition, Bordeaux University Hospital, Hôpital Haut-Lévêque, Avenue de Magellan, 33604, Pessac Cedex, France. [email protected].
³ Clinical Epidemiology Unit (USMR), CIC-EC 14-01, Bordeaux University Hospital, Bordeaux, France.
⁴ Univ. Bordeaux, INSERM, BMC, U1034, 33600, Pessac, France.
⁵ INSERM U1219-Bordeaux Population Health Research Center, Bordeaux, France.
⁶ Department of Endocrinology, Diabetes and Nutrition, Bordeaux University Hospital, Hôpital Haut-Lévêque, Avenue de Magellan, 33604, Pessac Cedex, France.
⁷ Internal Promotion Department, Bordeaux University Hospital, DCRI, Talence, France.
⁸ Department of Cardiology, Bordeaux University Hospital, Hôpital Haut-Lévêque, Pessac, France.
⁹ INSERM, Bordeaux Population Health Research Center, U1219, Team Pharmacoepidemiology, Bordeaux, France.
¹⁰ Department of Pharmacology, Bordeaux University Hospital, Bordeaux, France.
¹¹ INSERM, Bordeaux Population Health Research Center, U1219, Team EMOS, Bordeaux, France.

No abstract available

Publication types